FIELD: medicine.
SUBSTANCE: pre-operative fasting venous blood 1 ml is sampled at room temperature 20-24°C into an anticoagulant-free vacuum system (test tube). The test tubes are delivered in a sealed container at temperature 2-8°C for 2 hours to a laboratory for immunoenzyme assay and analysed to determine anti-thyroid stimulating hormone receptor antibodies. If the antibody level is 1.5 units/l or more, a thyroidectomy is performed, whereas the antibody level of less than 1.5 units/l requires performing a subtotal thyroid resection according to standard techniques.
EFFECT: invention enables reducing a probability of recurrent thyrotoxicosis in the patients after subtotal thyroid resection.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
| METHOD FOR PREDICTING DIFFUSE TOXIC GOITER CLINICAL COURSE | 2005 |
|
RU2291434C1 |
| METHOD FOR SELECTING SURGICAL TREATMENT VOLUME FOR THYROID DISEASES | 2020 |
|
RU2743706C1 |
| METHOD FOR SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 2005 |
|
RU2281040C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
| METHOD FOR PREDICTING THE VOLUME OF SURGICAL INTERVENTION AND CORRECTION OF POSTOPERATIVE HYPOTHYROIDISM IN PATIENTS WITH TOXIC FORMS OF GOITER | 2021 |
|
RU2774691C1 |
| METHOD FOR SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 2006 |
|
RU2294704C1 |
| METHOD OF TWO-STAGE SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 2023 |
|
RU2812101C1 |
| AGENT FOR PREVENTION OF POSTOPERATIVE LARYNGEAL PARESIS FOLLOWING THYROIDECTOMY | 2010 |
|
RU2446818C1 |
| METHOD OF TREATING DIFFUSE TOXIC GOITER | 1992 |
|
RU2028103C1 |
